Objectives: In trial-based economic evaluation, some individuals are typically associated with missing data at some time point, so that their corresponding aggregated outcomes (eg, quality-adjusted life-years) cannot be evaluated. Restricting the …
Patient-level health economic data collected alongside clinical trials are an important component of the process of technology appraisal, with a view to informing resource allocation decisions. For end of life treatments, such as cancer treatments, …
Health economic evaluations based on patient-level data collected alongside clinical trials (e.g. health related quality of life and resource use measures) are an important component of the process which informs resource allocation decisions. Almost …
Results from randomised trials show adding abiraterone acetate plus prednisolone (AAP) to standard of care (SOC) improves disease-free and overall survival in men with prostate cancer (PC) starting long-term hormone therapy for first time. Formal …
Statistical modelling of sports data has become more and more popular in the recent years and different types of models have been proposed to achieve a variety of objectives: from identifying the key characteristics which lead a team to win or lose …
Statistical modelling of sports data has become more and more popular in the recent years and different types of models have been proposed to achieve a variety of objectives: from identifying the key characteristics which lead a team to win or lose …
Trial-based economic evaluations are typically performed on cross-sectional variables, derived from the responses for only the completers in the study, using methods that ignore the complexities of utility and cost data (e.g. skewness and spikes). We …
Economic evaluations from individual level data are an important component of the process of technology appraisal, with a view to informing resource allocation decisions. A critical problem in these analyses is that both effectiveness and cost data …
Cost-effectiveness analyses (CEAs) alongside randomised controlled trials (RCTs) are increasingly designed to collect resource use and preference-based health status data for the purpose of healthcare technology assessment. However, because of the …